ExLibris header image
SFX Logo
Title: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
Source:

Nature Communications [2041-1723] yr:2015


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. De Felice, F. "Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors." Journal of Immunology Research 2015 (2015): 191832-7. Link to Full Text for this item Link to SFX for this item
2. Santoiemma, P. "Tumor Infiltrating Lymphocytes in Ovarian Cancer." Cancer biology & therapy 16.6 (2015): 807-20. Link to Full Text for this item Link to SFX for this item
3. Santin, Alessandro M. "Past, present and future targets for immunotherapy in ovarian cancer." Immunotherapy 6.12 (2014): 1279-93. Link to SFX for this item
4. Bjorklund, A. "Natural killer cell-mediated immunosurveillance of human cancer." Seminars in immunology 31 (2017): 20-29. Link to SFX for this item
5. Jimenez Sanchez, A. "Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient." Cell. 170.5: 927-4294967295. Link to SFX for this item
6. Spain, L. "Management of toxicities of immune checkpoint inhibitors." Cancer treatment reviews 44 (2016): 51-60. Link to SFX for this item
7. Andersen, R. "Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma." Human vaccines & immunotherapeutics 11.12 (2015): 2790-2795. Link to Full Text for this item Link to SFX for this item
8. Erfani, N. "FoxP3+ Regulatory T Cells in Peripheral Blood of Patients with Epithelial Ovarian Cancer." Iranian journal of immunology 11.2 (2014): 105-112. Link to SFX for this item
9. Zakharia, Y. "Ovarian Cancer from an Immune Perspective." Radiation Research 182.2 (2014): 239-51. Link to SFX for this item
10. Wu, R. "Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook." The cancer journal 18.2 (2012): 160-175. Link to SFX for this item
11. Small, Eric J J. "A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer." Clinical cancer research 13.6 (2007): 1810-5. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced